New Jersey Headlines

Aging Female Population and Rising Awareness Propel the Global Cervical Cancer Screening Market

Aging Female Population and Rising Awareness Propel the Global Cervical Cancer Screening Market

Global Cervical Cancer Screening Market is forecast to be US$ 7 Billion by 2020
Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA) Forecast is a 238 page market research report with 245 Figures and 15 Tables. Global Cervical Market is expected to be close to US$ 7 Billion by 2020. North America controls almost 50 percent Cervical Cancer Market. United States and Japan together makes more than 50 percent market share. In Europe region, United Kingdom and France are other top two leading countries in this market place.

One of the most widespread cancer diseases in Women globally is Cervical Cancer. Cervical cancer is a disease with the long hidden era, early on recognition and care of precancerous lesions were extremely effective in women who often take screening tests. Mostly in many incidences, the disease is recognized as Human Papilloma Virus (HPV) infection. But in many developed nations, the death rate because of cervical cancer screening has fallen down. Global Cervical Cancer Screening Market is forecast to be US$ 7 Billion by 2020.

Get Free 10% Customization in this Report

Click here for summary of the report with TOC: http://www.renub.com/global-cervical-cancer-screening-market-and-patients-by-test-type-pap-smear-hpv-dna-via-forecast-1009-p.php

How Cervical Cancer Occurs & their Symptoms

In cervical cancer malignant tumor is in the lower most part of the uterus (womb). Symptoms consist of bleeding in between periods and after sexual intercourse. Pain may also occur in lower back pain or lower abdominal and foul smelling white discharge. There are many cases when there are no symptoms found.

The Cervical cancer can be prevented by HPV vaccine as well as PAP smear screening. Surgery, Chemotherapy and Radiation are the treatment for cervical cancer. Ages and their occurrence can be distinguished in following manners.

Ages Occurrences
0 to2 Never
3 to 5 Never
6 to 13 Never
14 to 18 Very Rare
19 to 40 Rare
41 to 60 Rare
60+

View more reports about Diagnostics Reports by Renub Research at:

The Cervical cancer test includes Human Papilloma Virus (HPV) vaccine and PAP smear screening. Surgery, Chemotherapy and Radiation are the treatment for cervical cancer. Human Papilloma Virus (HPV) test occurs when the symptoms of HPV mainly causes infection in mouth, hand, genitals and fingers. Globally focus on HPV testing because of the rising awareness about and the link between HPV and Cervical cancer. PAP smear screening, been widely used as primary screening test for cervical cancer treatments. Changing the center on HPV testing as the primary screening test because of lower test sensitivity, higher negative results etc.

Cervical Cancer Test Market & Market Share: Overview

In Cervical cancer market 50 percent of the market share is jointly captured by the United States and Japan. In market research report, published by Renub Research found that Japan market will decline in future. The United Kingdom and France lead the cervical cancer market in Europe. Nations like India, China and Indonesia captures most of the cervical cancer test population.

Read the full PR: http://www.renub.com/aging-female-population-and-rising-awareness-propel-the-global-cervical-cancer-screening-market-40-nd.php

Challenges in Cervical Cancer Globally

Globally challenges of cervical cancer are the scarcity of gynecologists and pathologists, lack of awareness of diseases, lack of government facilities and policies in low income nations.

                                                           

The Report Studies the Global Cervical Cancer Screening Market on the basis of: Countries
1. United Kingdom
2. France
3. Germany
4. Italy
5. Spain
6. Sweden
7. Switzerland
8. Norway
9. Netherlands
10. United States
11. Canada
12. Japan
13. Korea
14. Singapore
15. Malaysia
16. Australia
17. India
18. China
19. Thailand
20. Indonesia

Cervical Cancer Test Market

• Pap Smear Test Market & Forecast
• HPV DNA Test Market & Forecast
• VIA Test Market & Forecast

Browse Related Reports :

Cervical Cancer Test Market & Patients (Pap Smear HPV DNA VIA) Asia (Japan, Korea, Singapore, Malaysia, India, China, Thailand, Indonesia)

 

About Us

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Media Contact
Company Name: Renub Research
Contact Person: Rajat Gupta
Email: Send Email
Phone: 6783020700
Address:225 Kristie Ln
City: Roswell
State: GA
Country: United States
Website: www.renub.com

Calendar

October 2017
M T W T F S S
« Sep    
 1
2345678
9101112131415
16171819202122
23242526272829
3031